As somatic mutations in KEAP1 occur across the entire gene and cause loss-of-function, it has been referred to as a tumour suppressor [161], and it has been proposed to drive cancers of the lung, head and neck, and liver [162,163]. This evidence concerns the gene KEAP1 and neoplasm.